Skip to main content
. 2022 Jul 7;13:895007. doi: 10.3389/fimmu.2022.895007

Figure 4.

Figure 4

Kaplan−Meier curves for patients with OMG based on risk group stratification in the development and validation cohorts. Patients were stratified into low- and high-risk generalization groups based on the optimal cut-off value (26%). Two-year cumulative generalization rates are presented for the development cohort (A) and validation cohort (B).